Psychiatric Pharmacogenetic Genotyping Panel
Related Gene(s): COMT, CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, DRD2, GRIK1, HTR2A, HTR2C, UGT2B15
Related Medication(s): Please see the Pharmacogenetic Medication and Gene Panels table for further information
Our Psychiatric Pharmacogenetic Genotyping Panel is designed to detect allelic and copy number variants in 11 drug response genes that are clinically actionable or informative on 58 medications. This test is intended to help physicians make therapeutic decisions for these selected medications that are indicated for patients with mental health disorders and which can have interindividual response variability.
For this test, targeted genotyping of functional sequence variants is performed using the Agena Biosciences platform and copy number variants interrogated for the CYP1A2, CYP2B6, CYP2C9, CYP2C19, and CYP2D6 genes by MLPA.
Specimen Requirements
- Blood: One 5-10 mL ACD tube (yellow top) and two 5-10 mL EDTA tubes (lavender top)
- Saliva: Saliva specimens are accepted in Oragene DNA (OG-500) kits by DNA Genotek
Ordering Information
Shipping
- Ship at room temperature
Turnaround Time
- 10-14 days from receipt of specimen
Related Tests
- Cardiovascular Pharmacogenetic Genotyping Panel
- Comprehensive Pharmacogenetic Genotyping Panel
- Epilepsy Pharmacogenetic Genotyping Panel
- Oncology Pharmacogenetic Genotyping Panel
- Pain Pharmacogenetic Genotyping Panel
- Pediatric Pharmacogenetic Genotyping Panel
- Targeted Pharmacogenetic Genotyping Panel
Resources
Psychiatric Pharmacogenetic Genotyping Panel Clinical Information Sheet
